Search Results - "Preillon, Julie"
-
1
Beyond PD-1: Investigating the Therapeutic Potential of TIGIT Blockade in DLBCL
Published in Blood (13-11-2019)“…Background: The PD-1/PD-L1 axis is a dominant cancer immune escape pathway, and PD-1 blockade therapy has greatly benefited patients with select solid tumors…”
Get full text
Journal Article -
2
Abstract 3249: a-TIGIT mediates antitumor activity through multiple mechanisms of action involving activation of intratumor effector T cells and depletion of regulatory T cells
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract T cell Immunoreceptor with Ig and ITIM domains (TIGIT) is a co-inhibitory receptor expressed by lymphocytes, preferentially CD8+ T cells, NK, as well…”
Get full text
Journal Article -
3
Restoration of T-cell Effector Function, Depletion of Tregs, and Direct Killing of Tumor Cells: The Multiple Mechanisms of Action of a-TIGIT Antagonist Antibodies
Published in Molecular cancer therapeutics (01-01-2021)“…TIGIT is an immune checkpoint inhibitor expressed by effector CD4 and CD8 T cells, NK cells, and regulatory T cells (Tregs). Inhibition of TIGIT-ligand binding…”
Get full text
Journal Article -
4
Abstract 3161: Preparation of aclinical trial with a-TIGIT antagonist antibody EOS884448, which demonstrates potent preclinical activity and safe toxicology profile
Published in Cancer research (Chicago, Ill.) (15-08-2020)“…Abstract T cell Immunoreceptor with Ig and ITIM domains (TIGIT) is a co-inhibitory receptor expressed by lymphocytes, preferentially CD8+, NK, as well as by…”
Get full text
Journal Article -
5
DMRT5 Together with DMRT3 Directly Controls Hippocampus Development and Neocortical Area Map Formation
Published in Cerebral cortex (New York, N.Y. 1991) (01-02-2018)“…Abstract Mice that are constitutively null for the zinc finger doublesex and mab-3 related (Dmrt) gene, Dmrt5/Dmrta2, show a variety of patterning…”
Get full text
Journal Article -
6
Abstract 4147: EOS100850, an A2Areceptor antagonist with prolonged pharmacodynamic activity, mediates the generation ofspecific durable immune responses in a murine breast cancer model
Published in Cancer research (Chicago, Ill.) (01-07-2019)“…Abstract We and others have shown that extracellular adenosine (Ado), acting predominantly through the A2A receptor (A2AR), mediates immunosuppression through…”
Get full text
Journal Article -
7
Abstract LB-114: a-TIGIT antagonist antibody EOS884448 shows dual mechanism of action by restoration of T cell effector functions and preferential depletion of Treg
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract T cell Immunoreceptor with Ig and ITIM domains (TIGIT) is a co-inhibitory receptor expressed by lymphocytes, preferentially CD8+ T cells, NK, as well…”
Get full text
Journal Article -
8
Abstract LB-291: EOS100850, an insurmountable and non-brain penetrant A2A receptor antagonist, inhibits adenosine-mediated T cell suppression, demonstrates anti-tumor activity and exhibits best-in class characteristics
Published in Cancer research (Chicago, Ill.) (01-07-2018)“…Abstract High levels of extracellular adenosine in the tumor microenvironment promote tumor immune evasion. We and others have shown that adenosine,…”
Get full text
Journal Article -
9
Abstract LB189: Pharmacodynamic assessment of a-TIGIT mAb EOS-448 highlights multiple FcγR-mediated mode-of-actions in blood and tumor of patients with advanced solid tumors
Published in Cancer research (Chicago, Ill.) (15-06-2022)“…Abstract T cell immunoglobulin and ITIM domain (TIGIT) is an immune checkpoint inhibitor expressed mainly on NK and T cell populations which has demonstrated…”
Get full text
Journal Article -
10
Macrophage migration inhibitory factor in head and neck squamous cell carcinoma: clinical and experimental studies
Published in Journal of cancer research and clinical oncology (01-05-2013)“…Purpose The present in vivo/in vitro study was undertaken in order to evaluate the importance of macrophage migration inhibitory factor (MIF) in the…”
Get full text
Journal Article -
11
Abstract 4863: PF-06840003: a highly selective IDO-1 inhibitor that shows good in vivo efficacy in combination with immune checkpoint inhibitors
Published in Cancer research (Chicago, Ill.) (15-07-2016)“…Abstract Tumors use tryptophan-catabolizing enzymes such as Indoleamine 2,3-dioxygenase-1 (IDO-1) to induce an immunosuppressive microenvironment. IDO-1…”
Get full text
Journal Article -
12
The Xenopus doublesex-related gene Dmrt5 is required for olfactory placode neurogenesis
Published in Developmental biology (01-01-2013)“…The Dmrt (doublesex and mab-3 related transcription factor) genes encode a large family of evolutionarily conserved transcription factors whose function in sex…”
Get full text
Journal Article